SCIMEDX PHASE II ANTI-PR3 ANTIBODY EIA (1282)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II ANTI-PR3 ANTIBODY EIA medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTE	COMPLEXITY
Anti-proteinase-3 (Pr-3) antibodies (K010287 | K010287)	HIGH Effective Date: 2001-03-28

Other General Immunology Devices:

Medical Device	Complexity
Sigma Diagnostics Test Kit	View Complexity
Beckman Coulter UniCel DxC 860i Synchron Access Clinical System	View Complexity
ReQuest EB NA IgG	View Complexity
Quest International Triturus� HSV IgG	View Complexity
Seradyn Color Slide	View Complexity
Bio-Chem Laboratory Systems ATAC 2000/2100	View Complexity
Bayer Advia 2400	View Complexity
Ventana c-erbB-2 Primary Antibody (clone CB11) with Ventana Nexes Slide Staining System	View Complexity
ORTHO CLINICAL DIAGNOSTICS VITROS ECI ANTI-HBC REAGENT PACK	View Complexity
Dade Behring Dimension Vista Integrated System	View Complexity